Showing results (1201-1210 of 1,376) with videos related to

Sort By:
Pageof 138
Nanomedicine : Nanotechnology, Biology, and Medicine|February 5, 2021
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancerZhen Ye, Mai Mohamed Abdelmoaty, Vishakha V Ambardekar, et al.
Angewandte Chemie (International Ed. in English)|September 16, 2016
Subtle Interactions and Electron Transfer between U(III) , Np(III) , or Pu(III) and Uranyl Mediated by the Oxo GroupPolly L Arnold, Michał S Dutkiewicz, Markus Zegke, et al.
Human Molecular Genetics|July 6, 2025
Metabolic rerouting of valine and isoleucine oxidation increases survival in zebrafish models of disorders of propionyl-CoA metabolismSungkook Hong, Joel Pardo, PamelaSara E Head, et al.
The New England Journal of Medicine|April 9, 2025
Tolebrutinib versus Teriflunomide in Relapsing Multiple SclerosisJiwon Oh, Douglas L Arnold, Bruce A C Cree, et al.
Journal of Managed Care & Specialty Pharmacy|April 28, 2017
The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid PopulationStephanie Tran, Pavel Lavitas, Karen Stevens, et al.
Molecular Genetics and Metabolism|December 25, 2007
A Delphi-based consensus clinical practice protocol for the diagnosis and management of 3-methylcrotonyl CoA carboxylase deficiencyGeorgianne L Arnold, Dwight D Koeberl, Dietrich Matern, et al.
The Lancet. Neurology|November 1, 2020
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trialJerry S Wolinsky, Douglas L Arnold, Bruno Brochet, et al.
Optics Letters|November 4, 2025
Impact of oblique reflections on the generation of isolated attosecond pulses by polarization gatingC Picot, D Diaz Rivas, N Ouahioune, et al.
Obesity (Silver Spring, Md.)|April 4, 2026
Effects of a 2-Year Primary Care Weight Loss Intervention on Quality of Life in Patients With ObesityKara D Denstel, Emily F Mire, Corby K Martin, et al.
The Lancet. Neurology|April 28, 2022
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trialJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Pageof 138